NRB Bearings Q1FY27: consol PAT +15% YoY (~9% ex one-off), NPM dips despite OPM gains

NRB Bearings' consolidated PAT for Q1 FY27 (quarter ended 30 June 2026) came in at ₹37.76 Cr, up 15.1% YoY from ₹32.81 Cr but down 10.3% QoQ from ₹42.09 Cr. Reported growth is flattered by a ₹2.65 Cr exceptional gain (insurance claim on the 2023 Waluj fire, sanctioned this quarter); stripping that out on an effective ~26.6% tax rate, adjusted PAT growth is a more modest ~9.2% YoY. Consolidated revenue rose a stronger 19.2% YoY to ₹369.53 Cr, though it was flat sequentially (-0.7% vs ₹371.98 Cr in Q4 FY26). Standalone PAT was ₹34.77 Cr on revenue of ₹319.89 Cr, with the roughly ₹50 Cr consolidated-standalone revenue gap coming from SNL Bearings, NRB Holdings UAE and the overseas step-down units. The margin picture is mixed. Operating margin (EBITDA/revenue) expanded 65bps YoY to 17.23% on volume-led operating leverage, though it eased from 18.01% in Q4 FY26 and sits below management's own 18-21% guided band. Net margin, by contrast, compressed to 10.07% from 10.27% a year ago and 11.11% last quarter — other income fell 41.9% YoY to ₹5.47 Cr (from ₹9.41 Cr) and depreciation rose 41% YoY to ₹18.35 Cr as the capex cycle ramps, partly cushioned by a 30% YoY drop in finance costs. Management issued no press release alongside this filing, so there is nothing fresh to grade beyond the last concall's guidance: sustaining EBITDA margins of 18-21% and 10-14% international-business growth for FY27, backed by a ₹120 Cr capacity capex plan. On margins the quarter sits just below the guided floor; the international-growth leg cannot be checked since NRB discloses a single 'Bearing' segment with no geography split. No verifiable street/consensus estimate for this quarter turned up in search, so vsStreet is unknown. The quarter's other developments — a ₹50 Cr corporate guarantee to HSBC for term loans at the new NRB Unitec (Mondial Group JV), and completion of the Mahant Tool Room acquisition (aerospace push) on 10 July 2026 with a further ₹30.5 Cr equity infusion — are balance-sheet/strategic moves rather than P&L drivers this quarter, but add to the capacity and diversification NRB will need to fund toward its own ₹2,500 Cr five-year revenue goal.